TR201821114A2 - Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m - Google Patents
Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m Download PDFInfo
- Publication number
- TR201821114A2 TR201821114A2 TR2018/21114A TR201821114A TR201821114A2 TR 201821114 A2 TR201821114 A2 TR 201821114A2 TR 2018/21114 A TR2018/21114 A TR 2018/21114A TR 201821114 A TR201821114 A TR 201821114A TR 201821114 A2 TR201821114 A2 TR 201821114A2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical composition
- efervescent
- erdostein
- effervescent
- erdosteine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- QGFORSXNKQLDNO-UHFFFAOYSA-N erdosteine Chemical class OC(=O)CSCC(=O)NC1CCSC1=O QGFORSXNKQLDNO-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Buluş, aktif etken madde olarak Erdostein ve / veya Erdostein?in farmasötik açıdan kabul edilebilir tuzları, esterleri, polimorfları, solvatları, enanatiomerleri ve / veya türevleri, 5 en az bir efervesan asit-baz çifti ve en az bir yardımcı madde içeren efervesan farmasötik bileşim ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17020598.3A EP3505164A1 (en) | 2017-12-31 | 2017-12-31 | An effervescent composition comprising erdosteine |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201821114A2 true TR201821114A2 (tr) | 2019-07-22 |
Family
ID=61258113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2018/21114A TR201821114A2 (tr) | 2017-12-31 | 2018-12-30 | Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3505164A1 (tr) |
TR (1) | TR201821114A2 (tr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114727952A (zh) * | 2019-10-17 | 2022-07-08 | Isp投资有限公司 | 稳定的泡腾共处理赋形剂组合物及其制备方法 |
IT202000016816A1 (it) * | 2020-07-10 | 2022-01-10 | Edmond Pharma Srl | Composizioni comprendenti composti antiossidanti come coadiuvanti nel trattamento di infezioni virali |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA963591B (en) * | 1995-05-10 | 1996-11-19 | Adcock Ingram Ltd | Pharmaceutical composition |
CN101181274A (zh) * | 2007-11-27 | 2008-05-21 | 北京润德康医药技术有限公司 | 一种以头孢克肟和厄多司坦为活性成分的药用组合物及其制备方法、用途 |
CN101199519A (zh) * | 2007-11-30 | 2008-06-18 | 北京润德康医药技术有限公司 | 含有环己西林或其衍生物的组合物及其制备方法 |
CN101214245A (zh) * | 2008-01-09 | 2008-07-09 | 北京润德康医药技术有限公司 | 含有环己西林或其衍生物的组合物及其制备方法 |
CN101612154A (zh) * | 2008-06-23 | 2009-12-30 | 广东肇庆星湖生物科技股份有限公司 | 含有匹氨西林的组合物及制备方法、用途 |
-
2017
- 2017-12-31 EP EP17020598.3A patent/EP3505164A1/en not_active Withdrawn
-
2018
- 2018-12-30 TR TR2018/21114A patent/TR201821114A2/tr unknown
Also Published As
Publication number | Publication date |
---|---|
EP3505164A1 (en) | 2019-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2020000145A2 (es) | Carboxamidas como moduladores de los canales de sodio | |
MX2021014509A (es) | Composiciones farmaceuticas que comprenden meloxicam. | |
CL2020001271A1 (es) | Inhibidores de kras g12c | |
DOP2022000115A (es) | Tetrahidrofuranos sustituidos como moduladores de canales de sodio | |
MA38399B2 (fr) | Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique | |
CY1121554T1 (el) | Παραγωγο πυρανοχρωμενυλ-φαινολης, και φαρμακευτικη συνθεση για αγωγη μεταβολικου συνδρομου ή φλεγμονωδους παθησης | |
EA201992116A1 (ru) | Фармацевтические составы флороглюцинола и триметилфлороглюцинола | |
CR20190332A (es) | Inhibidores selectivos de jak1 | |
BR112018009534A2 (pt) | composição farmacêutica contendo 2-{4-[n-(5,6-difenilpirazin-2-il)-n-isopropilamino]butiloxi }-n-(metilsulfonil)acetamida | |
TR201900680T4 (tr) | CXCR3 Reseptör modülatörleri olarak hidroksialkil- piperazin türevleri. | |
CR20180091A (es) | 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del vih | |
TR201821114A2 (tr) | Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m | |
CY1123527T1 (el) | Αντιφυματικος παραγοντας | |
CY1123185T1 (el) | Παραγωγα ινδολιου | |
BR112015032534A2 (pt) | usos de composto ou de sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, composições farmacêuticas e métodos para prevenir e/ou tratar encefalopatia traumática crônica ou condição relacionada em indivíduo e para tratar indivíduo com lesão de concussão | |
BR112018068170A2 (pt) | ácido (2s,4r)-5-(5?-cloro-2?-fluor-[1,1?-bifenil]-4-il)-2-(etoximetil)-4-(3-hidroxi-isoxazol-5-carboxamido)-2-metilpentanoico cristalino e usos dos mesmos | |
JOP20180071B1 (ar) | استخدام مشتقات أمينو ألكيل بنزوثيازبين | |
TR201721700A2 (tr) | Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari | |
BR112017014295A2 (pt) | composição farmacêutica. | |
TR201821115A2 (tr) | Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m | |
TR201815617A2 (tr) | Deksketoprofen içeren bir formülasyon. | |
TR201619983A2 (tr) | Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari | |
PH12016502527A1 (en) | Stabilized desmopressin | |
UA123395U (uk) | Фармацевтична композиція ністатину у формі оральної суспензії | |
TR201722630A2 (tr) |